{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:11:52Z","timestamp":1790878312623,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jid.2020.04.025","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:10:30Z","timestamp":1590145830000},"page":"2408-2420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Propranolol Is an Effective Topical and Systemic Treatment Option for Experimental Epidermolysis Bullosa Acquisita"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2455-2673","authenticated-orcid":false,"given":"Pia","family":"St\u00fcssel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8976-1767","authenticated-orcid":false,"given":"Katharina","family":"Schulze Dieckhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4992-5963","authenticated-orcid":false,"given":"Sven","family":"K\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7080-6160","authenticated-orcid":false,"given":"Veronika","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3473-0100","authenticated-orcid":false,"given":"Yask","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7988-7534","authenticated-orcid":false,"given":"Georg","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2016-0234","authenticated-orcid":false,"given":"Wendelien","family":"Veldkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-003X","authenticated-orcid":false,"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5846-7223","authenticated-orcid":false,"given":"Remco","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9794-7676","authenticated-orcid":false,"given":"Saeedeh","family":"Ghorbanalipoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4377-878X","authenticated-orcid":false,"given":"Kazuko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7775-8982","authenticated-orcid":false,"given":"Malin","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9847-8800","authenticated-orcid":false,"given":"Frank","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8929-4249","authenticated-orcid":false,"given":"Kathrin","family":"Kalies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1394-1737","authenticated-orcid":false,"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3855-6683","authenticated-orcid":false,"given":"Katja","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2020.04.025_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jdermsci.2018.01.012","article-title":"Autoinflammatory keratinization diseases: an emerging concept encompassing various inflammatory keratinization disorders of the skin","volume":"90","author":"Akiyama","year":"2018","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2020.04.025_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0006-2952(96)00212-2","article-title":"Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils","volume":"52","author":"Anderson","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jid.2020.04.025_bib3","first-page":"15","article-title":"The in\u00a0vitro effects of propranolol and atenolol on neutrophil motility and post-phagocytic metabolic activity","volume":"37","author":"Anderson","year":"1979","journal-title":"Immunology"},{"key":"10.1016\/j.jid.2020.04.025_bib4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fmed.2018.00238","article-title":"Comorbidities and treatment strategies in bullous pemphigoid: an appraisal of the existing litterature","volume":"5","author":"Bech","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2020.04.025_bib5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/exd.13415","article-title":"In\u00a0vitro and in\u00a0vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases","volume":"26","author":"Bieber","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2020.04.025_bib6","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.3389\/fimmu.2017.01628","article-title":"Regulatory T cells suppress inflammation and blistering in pemphigoid diseases","volume":"8","author":"Bieber","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2020.04.025_bib7","doi-asserted-by":"crossref","first-page":"38357","DOI":"10.1038\/srep38357","article-title":"T\u00a0cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita","volume":"6","author":"Bieber","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2020.04.025_bib8","doi-asserted-by":"crossref","first-page":"29355","DOI":"10.1016\/S0021-9258(18)43882-3","article-title":"The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization","volume":"269","author":"Bozic","year":"1994","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2020.04.025_bib9","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.pharep.2015.05.016","article-title":"Propranolol combined with dopamine has a synergistic action in intensifying and prolonging cutaneous analgesia in rats","volume":"67","author":"Chen","year":"2015","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.jid.2020.04.025_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/path.2157","article-title":"NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage","volume":"212","author":"Chiriac","year":"2007","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jid.2020.04.025_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1074-7613(01)00150-9","article-title":"Fc gamma RIII mediates neutrophil recruitment to immune complexes. A mechanism for neutrophil accumulation in immune-mediated inflammation","volume":"14","author":"Coxon","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2020.04.025_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.2908","article-title":"Propranolol for off-label treatment of patients with melanoma: results from a cohort study","volume":"4","author":"De Giorgi","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jid.2020.04.025_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jid.2020.04.025_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","article-title":"Initiation and use of propranolol for infantile hemangioma: report of a consensus conference","volume":"131","author":"Drolet","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jid.2020.04.025_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13052-017-0357-9","article-title":"Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience","volume":"43","author":"El Hachem","year":"2017","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jid.2020.04.025_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0006-291X(91)91581-V","article-title":"Divergent effects of propranolol on neutrophil superoxide release: involvement of phosphatidic acid and diacylglycerol as second messengers","volume":"175","author":"English","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jid.2020.04.025_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10517-006-0249-2","article-title":"Pathophysiological aspects of functional modulation of human peripheral blood neutrophils with propranolol","volume":"141","author":"Frolov","year":"2006","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.jid.2020.04.025_bib18","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archderm.1989.01670190059006","article-title":"Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid","volume":"125","author":"Grando","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2020.04.025_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.molmed.2016.05.003","article-title":"Autoinflammatory skin disorders: the inflammasomme in focus","volume":"22","author":"Gurung","year":"2016","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jid.2020.04.025_bib20","first-page":"1","article-title":"The allosteric CXCR1\/2 inhibitor DF2156A improves experimental epidermolysis bullosa acquisita","volume":"S3","author":"Hirose","year":"2013","journal-title":"Genet Syndr Gene Ther"},{"key":"10.1016\/j.jid.2020.04.025_bib21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2119\/molmed.2015.00206","article-title":"Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment","volume":"22","author":"Hirose","year":"2017","journal-title":"Mol Med"},{"key":"10.1016\/j.jid.2020.04.025_bib22","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","article-title":"Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany","volume":"136","author":"H\u00fcbner","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.04.025_bib23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00441-017-2774-x","article-title":"A\u00a0head-to-tail view of L-selectin and its impact on neutrophil behaviour","volume":"371","author":"Ivetic","year":"2018","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jid.2020.04.025_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13023-018-0896-1","article-title":"Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients","volume":"13","author":"Iwata","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jid.2020.04.025_bib25","doi-asserted-by":"crossref","first-page":"77825","DOI":"10.18632\/oncotarget.12833","article-title":"Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma","volume":"7","author":"Jean Wrobel","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2020.04.025_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A\u00a0comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.04.025_bib27","doi-asserted-by":"crossref","first-page":"15475","DOI":"10.1038\/ncomms15475","article-title":"Prevalence of sexual dimorphism in mammalian phenotypic traits","volume":"8","author":"Karp","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2020.04.025_bib28","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1002\/cpph.55","article-title":"Drug discovery for pemphigoid diseases","volume":"84","author":"Kasprick","year":"2019","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.jid.2020.04.025_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2340\/0001555570281285","article-title":"Increased levels of immunoreactive leukotriene B4 in blister fluids of bullous pemphigoid patients and effects of a selective 5-lipoxygenase inhibitor on experimental skin lesions","volume":"70","author":"Kawana","year":"1990","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2020.04.025_bib30","first-page":"33","article-title":"Myeloperoxidase as an active disease biomarker: recent biochemical and pathological perspectives","volume":"6","author":"Khan","year":"2018","journal-title":"Med Sci (Basel)"},{"key":"10.1016\/j.jid.2020.04.025_bib31","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrclinonc.2017.170","article-title":"Skin cancer: propranolol limits melanoma recurrence","volume":"14","author":"Killock","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jid.2020.04.025_bib32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fmed.2018.00362","article-title":"Epidermolysis bullosa acquisita: the 2019 update","volume":"5","author":"Koga","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2020.04.025_bib33","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.3389\/fimmu.2019.03012","article-title":"Fc\u03b3 receptor IIB controls skin inflammation in an active model of epidermolysis bullosa acquisita","volume":"10","author":"Kovacs","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2020.04.025_bib34","article-title":"Mechanisms of propranolol action in infantile hemangioma","volume":"6","author":"Kum","year":"2015","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.jid.2020.04.025_bib35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2340\/00015555-3052","article-title":"Unmet needs in pemphigoid diseases: an international survey amongst patients, clinicians and researchers","volume":"99","author":"Lamberts","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2020.04.025_bib36","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.04.025_bib37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A\u00a0randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.04.025_bib38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1056\/NEJMc1503811","article-title":"Oral propranolol for infantile hemangioma","volume":"373","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.04.025_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1189\/jlb.72.1.183","article-title":"Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine","volume":"72","author":"Ludwig","year":"2002","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jid.2020.04.025_bib40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2020.04.025_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/pde.12308","article-title":"A\u00a0retrospective study of propranolol therapy in 635 infants with infantile hemangioma","volume":"32","author":"Luo","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jid.2020.04.025_bib42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/pde.12089","article-title":"Propranolol and infantile hemangiomas four years later: a systematic review","volume":"30","author":"Marqueling","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jid.2020.04.025_bib43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/ijd.13517","article-title":"Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas","volume":"56","author":"Mashiah","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2020.04.025_bib44","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1111\/bph.14701","article-title":"Adrenoceptors-new roles for old players","volume":"176","author":"Michel","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jid.2020.04.025_bib45","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1158\/1078-0432.CCR-07-0481","article-title":"Myeloperoxidase is a key regulator of oxidative stress mediated apoptosis in myeloid leukemic cells","volume":"13","author":"Nakazato","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.04.025_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00281-015-0549-6","article-title":"Neutrophilic dermatoses and autoinflammatory diseases with skin involvement--innate immune disorders","volume":"38","author":"Navarini","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jid.2020.04.025_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/pde.13372","article-title":"Topical 1% propranolol ointment with occlusion in treatment of pyogenic granulomas: an open-label study in 22 children","volume":"35","author":"Neri","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jid.2020.04.025_bib48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41577-019-0141-8","article-title":"Heterogeneity of neutrophils","volume":"19","author":"Ng","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2020.04.025_bib49","first-page":"E17","article-title":"Expanding uses of propranolol in dermatology","volume":"99","author":"Oberlin","year":"2017","journal-title":"Cutis"},{"key":"10.1016\/j.jid.2020.04.025_bib50","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1021\/jm00124a021","article-title":"Design and synthesis of propranolol analogues as serotonergic agents","volume":"32","author":"Pierson","year":"1989","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jid.2020.04.025_bib51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bjd.13600","article-title":"Evidence and nuances of propranolol safety","volume":"172","author":"P\u00fcttgen","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2020.04.025_bib52","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.4049\/jimmunol.1400160","article-title":"Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex\u00a0vivo","volume":"193","author":"Recke","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2020.04.025_bib53","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1097\/PRS.0b013e31818cbf67","article-title":"Low-dose propranolol improves cutaneous wound healing of burn-injured rats","volume":"122","author":"Romana-Souza","year":"2008","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jid.2020.04.025_bib54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fphys.2018.00113","article-title":"Neutrophil: a cell with many roles in inflammation or several cell types?","volume":"9","author":"Rosales","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.jid.2020.04.025_bib55","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jlb.64.4.494","article-title":"The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia","volume":"64","author":"Rovai","year":"1998","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jid.2020.04.025_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/path.4556","article-title":"The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita","volume":"237","author":"Sadeghi","year":"2015","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jid.2020.04.025_bib57","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.4049\/jimmunol.1402688","article-title":"Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules","volume":"194","author":"Sadeghi","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2020.04.025_bib58","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000351557","article-title":"Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases","volume":"228","author":"Sagi","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2020.04.025_bib59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fimmu.2018.00249","article-title":"Whole-genome expression profiling in skin reveals SYK as a key regulator of inflammation in experimental epidermolysis bullosa acquisita","volume":"9","author":"Samavedam","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2020.04.025_bib60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fphar.2015.00171","article-title":"Adrenergic regulation of innate immunity: a review","volume":"6","author":"Scanzano","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jid.2020.04.025_bib61","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0190-9622(96)80146-0","article-title":"Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blisters of healthy control subjects","volume":"34","author":"Schmidt","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2020.04.025_bib62","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2249.2001.01503.x","article-title":"The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone","volume":"124","author":"Schmidt","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2020.04.025_bib63","first-page":"399","article-title":"The diagnosis and treatment of autoimmune blistering skin disorders","volume":"108","author":"Schmidt","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jid.2020.04.025_bib64","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2020.04.025_bib65","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jid.2016.12.021","article-title":"The leukotriene B4 and its receptor BLT1 act as critical drivers of neutrophil recruitment in murine bullous pemphigoid-like epidermolysis bullosa acquisita","volume":"137","author":"Sezin","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.04.025_bib66","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI200521386","article-title":"Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen","volume":"115","author":"Sitaru","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2020.04.025_bib67","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood.V11.5.436.436","article-title":"Studies on the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes","volume":"11","author":"Skoog","year":"1956","journal-title":"Blood"},{"key":"10.1016\/j.jid.2020.04.025_bib68","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nri.2017.10","article-title":"Neutrophils as protagonists and targets in chronic inflammation","volume":"17","author":"Soehnlein","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2020.04.025_bib69","doi-asserted-by":"crossref","first-page":"20481","DOI":"10.1016\/S0021-9258(19)88727-6","article-title":"Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C","volume":"267","author":"Sozzani","year":"1992","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2020.04.025_bib70","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10006-015-0528-z","article-title":"Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study","volume":"20","author":"Tiwari","year":"2016","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.jid.2020.04.025_bib71","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jid.2016.08.032","article-title":"Topically applied Hsp90 Blocker 17AAG inhibits autoantibody-mediated blister-inducing cutaneous inflammation","volume":"137","author":"Tukaj","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.04.025_bib72","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/exd.12680","article-title":"Heat shock protein 90 is required for ex\u00a0vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita","volume":"24","author":"Tukaj","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2020.04.025_bib73","first-page":"470","article-title":"Histamine 2 receptor-mediated immunomodulation in the mouse. I. Immunomodulation by the H2 agonist tolazoline","volume":"35","author":"Van Dijk","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2020.04.025_bib74","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12098-017-2303-7","article-title":"Efficacy and safety of 2% topical propranolol cream for the treatment of proliferating infantile strawberry hemangiomas","volume":"84","author":"Wang","year":"2017","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jid.2020.04.025_bib75","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1517\/14728222.2016.1148686","article-title":"Discovering potential drug-targets for personalized treatment of autoimmune disorders - what we learn from epidermolysis bullosa acquisita","volume":"20","author":"Witte","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jid.2020.04.025_bib76","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s000110050215","article-title":"Dapsone hydroxylamine inhibits the LTB4-induced chemotaxis of polymorphonuclear leukocytes into human skin: results of a pilot study","volume":"46","author":"Wozel","year":"1997","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jid.2020.04.025_bib77","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000211346","article-title":"Dapsone inhibits the generation of 5-lipoxygenase products in human polymorphonuclear leukocytes","volume":"8","author":"Wozel","year":"1995","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.jid.2020.04.025_bib78","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.joms.2016.04.021","article-title":"Clinical outcomes of infants with periorbital hemangiomas treated with oral propranolol","volume":"74","author":"Xue","year":"2016","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jid.2020.04.025_bib79","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.2147\/IJN.S164404","article-title":"Development and characterization of a nanoemulsion containing propranolol for topical delivery","volume":"13","author":"Zanela da Silva Marques","year":"2018","journal-title":"Int J Nanomedicine"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20315979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20315979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:19:42Z","timestamp":1758302382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X20315979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0022202X20315979"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2020.04.025","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Propranolol Is an Effective Topical and Systemic Treatment Option for Experimental Epidermolysis Bullosa Acquisita","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2020.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}